Augmentation de l’intervalle QT imputable à un traitement antiandrogénique, majorée par les psychotropes : à propos d’un cas

Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process

“…[30][31][32][33]), (2) adverse effects (e.g. [34][35][36][37][38][39]); in these two first sections, we described two cases in which clinical decisions were assisted by TDM [32,36]. "Pharmacopsy Alsace" is also involved in studies focusing on appropriate psychotropic use [40,41], the development of prescription support tools (anticholinergic impregnation scale for French psychiatry [42]) and training/information on psychotropic drugs [41,43].…”